image credit: The U.S. FDA / Wikimedia

FDA Commissioner Outlines Plans to Improve FDA Post-Pandemic

June 2, 2020


U.S. Food and Drug Administration (FDA) Commissioner Stephen M. Hahn recently gave a speech to the Alliance for a Stronger FDA. In it, he suggested that some of the changes forced on the agency by the COVID-19 pandemic are likely to become permanent.

Worth noting, as Hahn does, he took on the role of Commissioner of the FDA in December 2019, and was quickly thrust into an emergency footing because of the pandemic. Prior to taking on the role, he was chief medical executive at MD Anderson Cancer Center.

Read More on BioSpace